Have you read these stories?

Johnson & Johnson starts phase 3 vaccine trial

US drugmaker Johnson & Johnson says the vaccine could be available for use by early 2021 if proven safe, effective. In the next phase ...
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 05:02 AM IST | E-Paper
Search
+

    SEARCHED FOR:KKR

    KKR to throw another lifeline to JBF Industries

    All lenders have to agree to the KKR deal for the restructuring plan to go through.

    Load More...
    x
    The Economic Times